1. Advancing EJNMMI: continuing success and next developments

   • Ignasi Carrió
   • Arturo Chiti

   Editorial 04 October 2018 Pages: 2029 - 2031

   

2. Prostate cancer imaging: when the game gets tough, the hard one gets done!

   • Laura Evangelista
   • Matteo Sepulcri
   • Marco Maruzzo

   Editorial Commentary 21 July 2018 Pages: 2032 - 2034

3. ⁶⁸Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients

   • Paola Caroli
   • Israel Sandler
   • Giovanni Paganelli

   Original Article 19 June 2018 Pages: 2035 - 2044

   

4. Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer

   • Ali Afshar-Oromieh
   • Nils Debus
   • Uwe Haberkorn

   Original Article Open access 07 July 2018 Pages: 2045 - 2054

   

5. Diagnostic performance of ¹⁸F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer

   • Kambiz Rahbar
   • Ali Afshar-Oromieh
   • Matthias Weckesser

   Original Article Open access 20 July 2018 Pages: 2055 - 2061

   

6. Performance of ¹¹¹In-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy

   • Michael Mix
   • Kathrin Reichel
   • Cordula A. Jilg

   Original Article 30 July 2018 Pages: 2062 - 2070

   

7. FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients

   • E. Incerti
   • S. Broggi
   • Maria Picchio

   Original Article 06 June 2018 Pages: 2071 - 2078

   

8. Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging

   • Yonglin Pu
   • James X. Zhang
   • Bill C. Penney

   Original Article 07 June 2018 Pages: 2079 - 2092

   

9. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?

   • Benedikt Michael Schaarschmidt
   • Johannes Grueneisen
   • Thorsten Dirk Pöppel

   Original Article 06 June 2018 Pages: 2093 - 2102

   

10. How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience

    • Olarn Roengvoraphoj
    • Chukwuka Eze
    • Farkhad Manapov

    Original Article 06 June 2018 Pages: 2103 - 2109

    

11. Radioembolization with ⁹⁰Y glass microspheres for hepatocellular carcinoma: significance of pretreatment ¹¹C-acetate and ¹⁸F-FDG PET/CT and posttreatment ⁹⁰Y PET/CT in individualized dose prescription

    • Chi Lai Ho
    • Sirong Chen
    • Thomas Wai Tong Leung

    Original Article 11 June 2018 Pages: 2110 - 2121

    

12. What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis

    • Pierluigi Bonomo
    • A. Merlotti
    • S. Caini

    Original Article Open access 09 June 2018 Pages: 2122 - 2138

    

13. Prognostic value of posttreatment ¹⁸F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters

    • Giacomo Maria Lima
    • Antonella Matti
    • Stefano Fanti

    Original Article Open access 02 August 2018 Pages: 2139 - 2146

    

14. Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)

    • Onofrio A. Catalano
    • Lale Umutlu
    • Ciprian Catana

    Original Article 11 July 2018 Pages: 2147 - 2154

    

15. Postoperative serum thyroglobulin and neck ultrasound to drive decisions about iodine-131 therapy in patients with differentiated thyroid carcinoma: an evidence-based strategy?

    • Luca Giovanella
    • Anca M. Avram
    • Frederik A. Verburg

    Editorial 30 July 2018 Pages: 2155 - 2158

16. [¹⁸F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery

    • Sazan Rasul
    • Sabrina Hartenbach
    • Markus Hartenbach

    Original Article Open access 15 May 2018 Pages: 2159 - 2169

    

17. Quantification of myocardial blood flow with dynamic SPECT acquisitions: ready for prime time?

    • Fabien Hyafil
    • François Rouzet
    • Dominique Le Guludec

    Editorial Commentary 25 August 2018 Pages: 2170 - 2172

18. Feasibility of dynamic stress ²⁰¹Tl/rest ^99mTc-tetrofosmin single photon emission computed tomography for quantification of myocardial perfusion reserve in patients with stable coronary artery disease

    • Sangwon Han
    • Young-Hak Kim
    • Dae Hyuk Moon

    Original Article 02 June 2018 Pages: 2173 - 2180

    

19. Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease: a cross-correlation study with intravascular ultrasound

    • Li Li
    • Xiang Li
    • Sijin Li

    Original Article Open access 31 August 2018 Pages: 2181 - 2189

    

20. ¹⁸F-NaF and ¹⁸F-FDG as molecular probes in the evaluation of atherosclerosis

    • Mikaela L. McKenney-Drake
    • Mateen C. Moghbel
    • Abass Alavi

    Review Article Open access 06 July 2018 Pages: 2190 - 2200

    

21. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy

    • Sonja Stieb
    • Afroditi Eleftheriou
    • Oliver Riesterer

    Review Article 20 August 2018 Pages: 2201 - 2217

    

22. The SNMMI and EANM practice guideline for renal scintigraphy in adults

    • M. Donald Blaufox
    • Diego De Palma
    • Mark Tulchinsky

    Guidelines 30 August 2018 Pages: 2218 - 2228

23. Radiochemotherapy-induced reactivation of scar tissue on ¹⁸F-FDG PET/CT

    • Axel Van Damme
    • Fréderic Duprez
    • Ingeborg Goethals

    Image of the Month 11 August 2018 Pages: 2229 - 2230

    

24. Assessment of alteration in liver ¹⁸F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score

    • A. Michael Peters
    • Georgia Keramida
    • Deborah Pencharz

    Letter to the Editor 17 July 2018 Pages: 2231 - 2232

25. Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis

    • Nicolas Aide
    • Thibault Salomon
    • Charline Lasnon

    Reply 14 July 2018 Pages: 2233 - 2234

26. Could we avoid computing TMTV of DLBCL patients in routine practice?

    • Eric Laffon
    • Roger Marthan

    Letter to the Editor 28 July 2018 Pages: 2235 - 2237

    

27. ⁹⁰Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach

    • Luca Filippi
    • Orazio Schillaci
    • Oreste Bagni

    Letter to the Editor 07 August 2018 Pages: 2238 - 2239

    

28. Delivering PET imaging results to cancer patients: steps for handling ethical issues

    • Sandra Gonzalez
    • Eric Guedj
    • David Taïeb

    Letter to the Editor 14 August 2018 Pages: 2240 - 2241

29. Martin Vahlensieck and Maximilian Reiser (Eds). MRI of the Musculoskeletal System, Second Edition

    • Antonio D’Addio
    • Luigi Mansi

    Book Review 16 June 2018 Pages: 2242 - 2242

30. Wael E. A. Saad: Portal hypertension. Imaging, diagnosis, and endovascular management. Third edition

    • Viola Vultaggio
    • Luigi Mansi

    Book Review 18 June 2018 Pages: 2243 - 2243

31. Correction to: Regulation of human brown adipose tissue by adenosine and A_2A receptors – studies with [¹⁵O]H₂O and [¹¹C]TMSX PET/CT

    • Minna Lahesmaa
    • Vesa Oikonen
    • Kirsi A. Virtanen

    Correction 08 September 2018 Pages: 2244 - 2244

32. Correction to: PET imaging of EGFR expression using an ¹⁸F-labeled RNA aptamer

    • Siyuan Cheng
    • Orit Jacobson
    • Xiaoyuan Chen

    Correction 30 August 2018 Pages: 2245 - 2245